• / Free eNewsletters & Magazine
  • / My Account
Home>Galderma Announces Positive Outcome of European Decentralised Procedure for Approval of SOOLANTRA® (ivermectin) Cream 10mg/g for Rosacea Patients

Galderma Announces Positive Outcome of European Decentralised Procedure for Approval of SOOLANTRA® (ivermectin) Cream 10mg/g for Rosacea Patients

3party Content

Fri, 27 Mar 2015

Galderma Announces Positive Outcome of European Decentralised Procedure for Approval of SOOLANTRA® (ivermectin) Cream 10mg/g for Rosacea Patients
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.